Trial NCT02614508

View at ClinicalTrials.gov 
Org. Study IDs: IRB00071983
Secondary IDs: NCI-2015-00652 Winship2494-13/CBKM120ZUS36T

Last trial update was posted on 2019-09-03

MeSH Interventions

Antibodies, Monoclonal Ibrutinib Ofatumumab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma Recurrence

Other Conditions

Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID